Annual Working Capital
$9.36 M
-$1.22 M-11.55%
June 1, 2024
Summary
- As of February 26, 2025, NEUP annual working capital is $9.36 million, with the most recent change of -$1.22 million (-11.55%) on June 1, 2024.
- During the last 3 years, NEUP annual working capital has fallen by -$12.10 million (-56.37%).
Performance
NEUP Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Working Capital
$2.26 M
-$3.61 M-61.47%
December 1, 2024
Summary
- As of February 26, 2025, NEUP quarterly working capital is $2.26 million, with the most recent change of -$3.61 million (-61.47%) on December 1, 2024.
- Over the past year, NEUP quarterly working capital has stayed the same.
Performance
NEUP Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Working Capital Formula
Working Capital = Current Assets − Current Liabilities
NEUP Working Capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -11.6% | 0.0% |
| 3 y3 years | -56.4% | - |
| 5 y5 years | +18.0% | +97.6% |
NEUP Working Capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.6% | at low | -92.4% | at low |
| 5 y | 5-year | -64.6% | -99.6% | -92.4% | -181.7% |
| alltime | all time | -73.1% | -103.5% | -93.5% | -181.7% |
Neuphoria Therapeutics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $2.26 M(-61.5%) |
| Sep 2024 | - | $5.88 M(-37.2%) |
| Jun 2024 | - | $9.36 M(+10.6%) |
| Jun 2024 | $9.36 M(-11.6%) | - |
| Dec 2023 | - | $8.47 M(-20.0%) |
| Jun 2023 | $10.59 M(-60.0%) | $10.59 M(-47.2%) |
| Dec 2022 | - | $20.06 M(-24.2%) |
| Jun 2022 | $26.45 M(+23.3%) | $26.45 M(-11.6%) |
| Dec 2021 | - | $29.93 M(+39.4%) |
| Jun 2021 | $21.46 M(>+9900.0%) | $21.46 M(-1260.5%) |
| Dec 2020 | - | -$1.85 M(-4524.4%) |
| Jun 2020 | $41.80 K(-99.5%) | $41.80 K(-96.4%) |
| Dec 2019 | - | $1.15 M(-85.6%) |
| Jun 2019 | $7.93 M(-52.3%) | $7.93 M(-43.5%) |
| Dec 2018 | - | $14.04 M(-15.6%) |
| Jun 2018 | $16.63 M(-46.7%) | $16.63 M(-45.0%) |
| Dec 2017 | - | $30.25 M(-3.0%) |
| Jun 2017 | $31.19 M(-10.6%) | $31.19 M(+15.8%) |
| Dec 2016 | - | $26.93 M(-22.8%) |
| Jun 2016 | $34.87 M(+88.1%) | $34.87 M(+3.0%) |
| Dec 2015 | - | $33.87 M(+82.7%) |
| Jun 2015 | $18.54 M(-34.9%) | $18.54 M(-36.8%) |
| Dec 2014 | - | $29.36 M(+3.1%) |
| Jun 2014 | $28.47 M(+26.6%) | $28.47 M(+62.5%) |
| Dec 2013 | - | $17.52 M(-22.1%) |
| Jun 2013 | $22.48 M | $22.48 M(+60.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $13.98 M(-20.9%) |
| Jun 2012 | $17.67 M(-14.8%) | $17.67 M(+6.4%) |
| Dec 2011 | - | $16.60 M(-19.9%) |
| Jun 2011 | $20.74 M(+128.9%) | $20.74 M(+48.9%) |
| Dec 2010 | - | $13.93 M(+53.8%) |
| Jun 2010 | $9.06 M(+262.5%) | $9.06 M(-29.5%) |
| Dec 2009 | - | $12.86 M(+414.6%) |
| Jun 2009 | $2.50 M(-55.0%) | $2.50 M(+71.2%) |
| Dec 2008 | - | $1.46 M(-73.7%) |
| Jun 2008 | $5.55 M(-36.7%) | $5.55 M(-4.2%) |
| Dec 2007 | - | $5.80 M(-33.9%) |
| Jun 2007 | $8.77 M(+377.3%) | $8.77 M(+129.7%) |
| Dec 2006 | - | $3.82 M(+107.8%) |
| Jun 2006 | $1.84 M(-67.4%) | $1.84 M(-47.2%) |
| Dec 2005 | - | $3.48 M(-38.3%) |
| Jun 2005 | $5.64 M(+6.7%) | $5.64 M(+22.6%) |
| Dec 2004 | - | $4.60 M(-13.0%) |
| Jun 2004 | $5.29 M(+57.8%) | $5.29 M(+108.7%) |
| Dec 2003 | - | $2.53 M(-24.4%) |
| Jun 2003 | $3.35 M(-25.5%) | $3.35 M(+5.9%) |
| Dec 2002 | - | $3.16 M(-29.7%) |
| Jun 2002 | $4.50 M(-5.9%) | $4.50 M(-12.2%) |
| Dec 2001 | - | $5.12 M(+7.1%) |
| Jun 2001 | $4.78 M(+77.4%) | $4.78 M(+10.3%) |
| Dec 2000 | - | $4.33 M |
| Jun 2000 | $2.70 M(-915.8%) | - |
| Jun 1999 | -$330.40 K | - |
FAQ
- What is Neuphoria Therapeutics annual working capital?
- What is the all time high annual working capital for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics annual working capital year-on-year change?
- What is Neuphoria Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Neuphoria Therapeutics?
- What is Neuphoria Therapeutics quarterly working capital year-on-year change?
What is Neuphoria Therapeutics annual working capital?
The current annual working capital of NEUP is $9.36 M
What is the all time high annual working capital for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high annual working capital is $34.87 M
What is Neuphoria Therapeutics annual working capital year-on-year change?
Over the past year, NEUP annual working capital has changed by -$1.22 M (-11.55%)
What is Neuphoria Therapeutics quarterly working capital?
The current quarterly working capital of NEUP is $2.26 M
What is the all time high quarterly working capital for Neuphoria Therapeutics?
Neuphoria Therapeutics all-time high quarterly working capital is $34.87 M
What is Neuphoria Therapeutics quarterly working capital year-on-year change?
Over the past year, NEUP quarterly working capital has changed by $0.00 (0.00%)